The chamber had been in operation for three years. The IQ was complete. The OQ was complete. The documentation was in order. The continuous monitoring system showed conditions within specification throughout every study that had been run in it.
When the regulatory assessor asked for the OQ temperature mapping data, the quality team provided it. The mapping had been conducted over 72 hours in an empty chamber. Nine probe positions. All within ±0.6°C of setpoint. Clean data, clean documentation.
The assessor asked one further question: had the mapping been conducted under loaded conditions?
It had not. The OQ had qualified an empty chamber. The studies had been run in a loaded chamber. The two conditions had never been shown to be equivalent.
This is the most common compliance gap in pharmaceutical stability chamber qualification — not a failure to qualify, but a failure to qualify under the conditions of use.
What ICH Q1A actually requires
ICH Q1A(R2) — Stability Testing of New Drug Substances and Products — defines the environmental conditions for stability studies. For new drug products, the standard conditions are:
The tolerance values — ±2°C and ±5% RH — are the compliance parameters. A chamber that deviates beyond these limits during the study period produces data that may not be acceptable to regulatory authorities. ICH Q1A does not specify the qualification method; it specifies the performance requirement. EU GMP Annex 15 specifies how that performance must be demonstrated.
The IQ/OQ/PQ sequence
EU GMP Annex 15 requires that equipment used in GMP-regulated processes be qualified through a documented sequence of Installation Qualification, Operational Qualification, and Performance Qualification. Each phase has defined objectives and cannot be started without the preceding phase being approved.
IQ — Installation Qualification. Verifies that the chamber has been installed correctly and that its components, technical documentation, and utilities comply with the project and supplier specifications. The IQ checks: chamber identity and configuration against purchase specification; calibration certificates for sensors and probes; utilities — electrical supply, water supply if water-cooled, drain; safety systems — over-temperature protection, alarm connections; software version and configuration documentation.
OQ — Operational Qualification. Demonstrates that the chamber performs to specification throughout its intended operating range. The OQ includes temperature and humidity mapping — a systematic survey of conditions at multiple points within the chamber volume over a defined period. The OQ must include:
Minimum 9 probe positions in a standard walk-in or reach-in chamber, distributed across the three-dimensional volume. Duration: minimum 72 hours at each setpoint condition. Acceptance criteria: all positions within ±0.5°C of setpoint and within ±0.5°C of each other.
The chamber is loaded with a product load representative of maximum anticipated density. The mapping is repeated with distributed probes at product level. This is the step most commonly omitted — and the step most commonly challenged in regulatory inspection.
The time required for the chamber to return to setpoint conditions after a door opening representative of routine use. This must be measured and documented — recovery time affects the validity of data collected immediately after access events.
Confirmation that the alarm system activates at the configured deviation limits and that the alarm is received by the monitoring system or designated personnel within the required response time.
PQ — Performance Qualification. Demonstrates that the chamber performs to specification under actual conditions of use — including product load, access patterns, and environmental conditions representative of the installation site. The PQ is conducted after the OQ and before the chamber is used for regulatory stability studies.
Why the OQ must be done under load
A walk-in stability chamber loaded with product has different thermal characteristics from the same chamber when empty. The product load absorbs and releases heat, creates airflow resistance at the shelf level, and changes the thermal equilibrium of the space. The temperature distribution seen in an empty mapping is not representative of the temperature distribution under operational load.
EU GMP Annex 15 is explicit: qualification must demonstrate fitness for purpose under conditions of use. An OQ conducted on an empty chamber demonstrates that the empty chamber meets specification. It does not demonstrate — and cannot be used to demonstrate — that the loaded chamber meets specification.
Where the monitoring system sits
The continuous monitoring system — the sensor or sensors that record conditions during the study and trigger alarms — must be positioned at product level, not at the chamber controller sensor. This is a distinction that appears straightforward but is frequently implemented incorrectly.
The chamber controller sensor is typically positioned near the air circulation system, in an area of high airflow and relatively uniform temperature. It is designed to control the chamber — to measure the condition of the air being circulated. It is not designed to measure the condition of the product on the shelf.
For ICH Q1A compliance, the relevant temperature is the temperature at product level. A monitoring system calibrated to the controller sensor may show conditions within specification while product-level temperatures deviate — as Case #002 in this series illustrates.
The PQ — and why it is not optional
The Performance Qualification is the phase that connects the OQ (demonstration of performance within specification) to actual use. The PQ confirms that the chamber performs to specification in its operational configuration — with the product load, access patterns, and environmental conditions that will be present during the study.
For stability chambers, the PQ typically includes a minimum of 7 to 30 days of continuous monitoring at each setpoint condition, with the chamber loaded and operated according to normal use. The acceptance criteria must match or exceed the ICH Q1A tolerance requirements.
A chamber that completes IQ and OQ but has not completed PQ is not qualified for regulatory stability studies. A study conducted in a chamber without a valid PQ has a qualification gap that will require justification in a regulatory submission or inspection.
Re-qualification is required after any significant modification to the chamber — including refrigerant change (see the R-449A retrofit guide for what this means for F-Gas compliance), sensor replacement, relocation, or any maintenance that could affect thermal performance.
Re-qualification triggers
EU GMP Annex 15 requires that equipment be maintained in a qualified state throughout its operational life. Re-qualification is triggered by:
Modification. Any change to the chamber configuration, refrigeration system, sensors, control software, or physical location requires re-qualification. The scope of re-qualification depends on the nature and extent of the change — a sensor replacement may require only OQ re-mapping; a refrigerant change typically requires full OQ and PQ.
Out-of-specification event. A documented excursion beyond the ICH Q1A tolerance limits requires investigation, root cause analysis, and — depending on the findings — re-qualification of the affected chamber.
Periodic re-qualification. EU GMP Annex 15 does not specify a fixed re-qualification interval. The frequency is determined by risk assessment considering the criticality of the chamber, historical performance data, and the ISPE Controlled Temperature Chambers Good Practice Guide (2nd edition, 2021), which recognises continuous monitoring as an alternative to periodic re-mapping when properly documented.
What an audit will check
A regulatory inspection of a pharmaceutical stability programme will typically request the following documentation for each chamber used:
IQ, OQ, and PQ protocols and reports — including the acceptance criteria used and the results achieved. The assessor will check whether the OQ included loaded temperature mapping and whether the PQ was conducted before the chamber was placed into service for regulatory studies.
Calibration certificates — for all temperature and humidity sensors, current and for the duration of the studies being assessed.
Continuous monitoring data — the complete record of conditions throughout the study period, at product-level sensor positions. The assessor will check whether any excursions occurred and whether they were investigated and closed.
Re-qualification records — confirming that the chamber was re-qualified after any significant event or modification during the study period.
Alarm records and response logs — documentation of any alarm events, the response taken, and the impact assessment on affected samples.
EU GMP Annex 15, Qualification and Validation, European Commission, 2015.
ISPE Controlled Temperature Chambers Good Practice Guide, 2nd edition, 2021.
EU GMP Annex 11, Computerised Systems, European Commission, 2011.
If your OQ was conducted on an empty chamber, the loaded qualification has not been done. That gap will be identified in an audit.
See Case #002 for the regulatory consequence →Frequently asked questions
Does ICH Q1A specify the same storage conditions for all markets?
No — ICH Q1A(R2) defines conditions by climatic zone. Zone I/II markets (Europe, US) use 25°C/60% RH for long-term studies; Zones III/IV (hot/dry or hot/humid climates) use 30°C/65% RH or 30°C/75% RH. Many manufacturers test at the most demanding zone (IVb: 30°C/75% RH) to cover all markets in a single study.
What is the difference between OQ and PQ for a stability chamber, and why does it matter?
OQ (Operational Qualification) confirms the chamber operates within specification — typically tested empty. PQ (Performance Qualification) confirms it performs under actual use conditions, meaning loaded with product containers in the configuration used during studies. FDA inspectors have specifically cited missing loaded-condition mapping as a finding; the OQ alone does not validate that every sample in a study was held within ICH tolerance.
Can a standard climatic test chamber be used for ICH pharmaceutical stability studies?
Not reliably — industrial climatic chambers are designed for short-duration tests at extreme conditions, not sustained precision at moderate conditions over months or years. Pharmaceutical stability chambers are specifically engineered for the ±0.5°C uniformity, ±2% RH control, and continuous data logging ICH Q1A requires across study durations of 12–36 months.
Is DO-160 testing required for all aircraft equipment, or only avionics?
DO-160 applies to all airborne equipment — not just avionics electronics. Communication systems, navigation systems, mechanical actuators, lighting, and any hardware intended for installation on certified aircraft may require DO-160 qualification. Which of the 26 sections apply depends on the equipment's installation location and function.
Does a product that passes MIL-STD-810 automatically satisfy DO-160 requirements?
No. MIL-STD-810 is a tailoring methodology that derives conditions from field data; DO-160 specifies fixed test categories. A product qualified to MIL-STD-810 default temperature and vibration conditions has not necessarily been tested to the specific DO-160 categories its installation location requires, and MIL-STD-810 test data is not accepted as DO-160 compliance evidence by FAA or EASA.
Newsletter
The Test Report
Written for engineers who've unsubscribed from everything else.